Achillion Pharma (ACHN) Posts Narrower than Expected Q2 Loss of 16c/Share
Tweet
Share
E-mailGet Alerts ACHN Hot Sheet
Price: $0.79 --0%
Financial Fact:
Total operating expenses: 21.55M
Today's EPS Names:
FRMM, PETS, DARE, More
Financial Fact:
Total operating expenses: 21.55M
Today's EPS Names:
FRMM, PETS, DARE, More
Join SI Premium – FREE
Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) reported Q2 EPS of ($0.16), $0.01 better than the analyst estimate of ($0.17).
For earnings history and earnings-related data on Achillion Pharmaceuticals, Inc. (ACHN) click here.
For earnings history and earnings-related data on Achillion Pharmaceuticals, Inc. (ACHN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- JPMorgan Upgrades Kolmar Korea Co Ltd (161890:KS) to Overweight
- UBS Upgrades Mitsubishi Heavy Industries Ltd (7011:JP) (MHVYF) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
